MicroRNA-382 induced by HIF-1α is an angiogenic miR targeting the tumor suppressor phosphatase and tensin homolog

Nucleic Acids Research

Volumn 42, Issue 12, 2014, Pages 8062-8072

  Seok, Jin Kyung ^a,b   Lee, Sun Hee ^a   Kim, Min Jung ^a,b   Lee, You Mie ^a,b  

^a Research Institute of Pharmaceutical Sciences   (South Korea)

^b Kyungpook National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTAGOMIR; ANTAGOMIR 382; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LUCIFERASE; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; MICRORNA 382; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; VASCULOTROPIN;

3' UNTRANSLATED REGION; ALGORITHM; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CAPILLARY DENSITY; CELL HYPOXIA; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN MKN1; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME REPRESSION; GENE DELETION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROTEIN RNA BINDING; PROTEIN SECRETION; RECEPTOR DOWN REGULATION; RNA SEQUENCE; SIGNAL TRANSDUCTION; STOMACH CANCER; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; UPREGULATION; VASCULAR ENDOTHELIUM;

ANIMALS; CELL HYPOXIA; CELL LINE, TUMOR; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE, NUDE; MICRORNAS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; STOMACH NEOPLASMS; TOR SERINE-THREONINE KINASES;

EID: 84903954676     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku515     Document Type: Article

References (51)

1. Semenza, G.L. (2014) Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annu. Rev. Pathol., 9, 47-71.
2. Boutin, A.T., Weidemann, A., Fu, Z., Mesropian, L., Gradin, K., Jamora, C., Wiesener, M., Eckardt, K.U., Koch, C.J., Ellies, L.G. et al. (2008) Epidermal sensing of oxygen is essential for systemic hypoxic response. Cell, 133, 223-234.
3. Mandriota, S.J., Turner, K.J., Davies, D.R., Murray, P.G., Morgan, N.V., Sowter, H.M., Wykoff, C.C., Maher, E.R., Harris, A.L., Ratcliffe, P.J. et al. (2002) HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron. Cancer Cell, 1, 459-468.
4. Semenza, G.L. (2012) Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol. Sci., 33, 207-214.
5. Ahluwalia, A., Tarnawski, A.S. (2012) Critical role of hypoxia sensor-HIF-1alpha in VEGF gene activation. Implications for angiogenesis and tissue injury healing. Curr. Med. Chem., 19, 90-97.
6. Claes, A., Leenders, W. (2008) Vessel normalization by VEGF inhibition. A complex story. Cancer Biol. Ther., 7, 1014-1016.
7. Bartel, D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-297.
8. He, L., Hannon, G.J. (2004) MicroRNAs: small RNAs with a big role in gene regulation.Nat. Rev. Genet., 5, 522-531.
9. Shenouda, S.K., Alahari, S.K. (2009) MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer Metastasis Rev., 28, 369-378.
10. Lee, R.C., Feinbaum, R.L., Ambros, V. (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75, 843-854.
11. Kozomara, A., Griffiths-Jones, S. (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res., 39, D152-D157.
12. Karp, X., Ambros, V. (2005) Developmental biology. Encountering microRNAs in cell fate signaling. Science, 310, 1288-1289.
13. Miska, E.A. (2005) How microRNAs control cell division, differentiation and death. Curr. Opin. Genet. Dev., 15, 563-568.
14. Kloosterman, W.P., Plasterk, R.H. (2006) The diverse functions of microRNAs in animal development and disease. Dev. Cell, 11, 441-450.
15. Liu, J., Albrecht, A.M., Ni, X., Yang, J., Li, M. (2013) Glioblastoma tumor initiating cells: therapeutic strategies targeting apoptosis and microRNA pathways. Curr. Mol. Med., 13, 352-357.
16. Wang, S., Olson, E.N. (2009) AngiomiRs-key regulators of angiogenesis. Curr. Opin. Genet. Dev., 19, 205-211.
17. Chan, S.Y., Loscalzo, J. (2010) MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle, 9, 1072-1083.
18. Yang, C., Cai, J., Wang, Q., Tang, H., Cao, J., Wu, L., Wang, Z. (2012) Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1. Gynecol. Oncol., 124, 325-334.
19. Yip, L., Kelly, L., Shuai, Y., Armstrong, M.J., Nikiforov, Y.E., Carty, S.E., Nikiforova, M.N. (2011) MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma. Ann. Surg. Oncol., 18, 2035-2041.
20. Zhou, Y.J., Xiong, Y.X., Wu, X.T., Shi, D., Fan, W., Zhou, T., Li, Y.C., Huang, X. (2004) Inactivation of PTEN is associated with increased angiogenesis and VEGF overexpression in gastric cancer. World J. Gastroenterol., 10, 3225-3229.
21. Vazquez, F., Sellers, W.R. (2000) The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling. Biochim. Biophys. Acta, 1470, M21-M35.
22. Snaddon, J., Parkinson, E.K., Craft, J.A., Bartholomew, C., Fulton, R. (2001) Detection of functional PTEN lipid phosphatase protein and enzyme activity in squamous cell carcinomas of the head and neck, despite loss of heterozygosity at this locus. Br. J. Cancer, 84, 1630-1634.
23. Blanco-Aparicio, C., Renner, O., Leal, J.F., Carnero, A. (2007) PTEN, more than the AKT pathway. Carcinogenesis, 28, 1379-1386.
24. Harris, A.L. (2002) Hypoxia-a key regulatory factor in tumour growth. Nat. Rev. Cancer, 2, 38-47.
25. Semenza, G.L. (2003) Angiogenesis in ischemic and neoplastic disorders. Annu. Rev. Med., 54, 17-28.
26. Chan, S.Y., Zhang, Y.Y., Hemann, C., Mahoney, C.E., Zweier, J.L., Loscalzo, J. (2009) MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab., 10, 273-284.
27. Huang, X., Ding, L., Bennewith, K.L., Tong, R.T., Welford, S.M., Ang, K.K., Story, M., Le, Q.T., Giaccia, A.J. (2009) Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol. Cell, 35, 856-867.
28. Chen, Z., Lai, T.C., Jan, Y.H., Lin, F.M., Wang, W.C., Xiao, H., Wang, Y.T., Sun, W., Cui, X., Li, Y.S. et al. (2013) Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesis. J. Clin. Invest., 123, 1057-1067.
29. Zhou, B., Ma, R., Si, W., Li, S., Xu, Y., Tu, X., Wang, Q. (2013) MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth. Cancer Lett., 333, 159-169.
30. Liu, L.Z., Li, C., Chen, Q., Jing, Y., Carpenter, R., Jiang, Y., Kung, H.F., Lai, L., Jiang, B.H. (2011) MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1alpha expression. PLoS One, 6, e19139.
31. Jones, P.A., Baylin, S.B. (2007) The epigenomics of cancer. Cell, 128, 683-692.
32. Chalhoub, N., Baker, S.J. (2009) PTEN and the PI3-kinase pathway in cancer. Annu. Rev. Pathol., 4, 127-150.
33. Huse, J.T., Brennan, C., Hambardzumyan, D., Wee, B., Pena, J., Rouhanifard, S.H., Sohn-Lee, C., le Sage, C., Agami, R., Tuschl, T. et al. (2009) The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev., 23, 1327-1337.
34. Wang, B., Majumder, S., Nuovo, G., Kutay, H., Volinia, S., Patel, T., Schmittgen, T.D., Croce, C., Ghoshal, K., Jacob, S.T. (2009) Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. Hepatology, 50, 1152-1161.
35. Yang, H., Kong, W., He, L., Zhao, J.J., O'Donnell, J.D., Wang, J., Wenham, R.M., Coppola, D., Kruk, P.A., Nicosia, S.V. et al. (2008) MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res., 68, 425-433.
36. Pore, N., Jiang, Z., Shu, H.K., Bernhard, E., Kao, G.D., Maity, A. (2006) Akt1 activation can augment hypoxia-inducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathway. Mol. Cancer Res., 4, 471-479.
37. Hong, L., Han, Y., Zhang, H., Zhao, Q., Qiao, Y. (2013) miR-210: a therapeutic target in cancer. Expert Opin. Ther. Targets, 17, 21-28.
38. McCormick, R.I., Blick, C., Ragoussis, J., Schoedel, J., Mole, D.R., Young, A.C., Selby, P.J., Banks, R.E., Harris, A.L. (2013) miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis. Br. J. Cancer, 108, 1133-1142.
39. Santarelli, D.M., Beveridge, N.J., Tooney, P.A., Cairns, M.J. (2011) Upregulation of dicer and microRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia. Biol. Psychiatry, 69, 180-187.
40. Mor, E., Kano, S., Colantuoni, C., Sawa, A., Navon, R., Shomron, N. (2013) MicroRNA-382 expression is elevated in the olfactory neuroepithelium of schizophrenia patients. Neurobiol. Dis., 55, 1-10.
41. Kriegel, A.J., Fang, Y., Liu, Y., Tian, Z., Mladinov, D., Matus, I.R., Ding, X., Greene, A.S., Liang, M. (2010) MicroRNA-target pairs in human renal epithelial cells treated with transforming growth factor beta 1: a novel role of miR-382. Nucleic Acids Res., 38, 8338-8347.
42. Zeisberg, M., Neilson, E.G. (2009) Biomarkers for epithelial-mesenchymal transitions. J. Clin. Invest., 119, 1429-1437.
43. Kriegel, A.J., Liu, Y., Cohen, B., Usa, K., Liu, Y., Liang, M. (2012) MiR-382 targeting of kallikrein 5 contributes to renal inner medullary interstitial fibrosis. Physiol. Genomics, 44, 259-267.
44. Thayanithy, V., Sarver, A.L., Kartha, R.V., Li, L., Angstadt, A.Y., Breen, M., Steer, C.J., Modiano, J.F., Subramanian, S. (2012) Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma. Bone, 50, 171-181.
45. Sarver, A.L., Thayanithy, V., Scott, M.C., Cleton-Jansen, A.M., Hogendoorn, P.C., Modiano, J.F., Subramanian, S. (2013) MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma. Orphanet J. Rare Dis., 8, 7.
46. Li, Z., Lu, J., Sun, M., Mi, S., Zhang, H., Luo, R.T., Chen, P., Wang, Y., Yan, M., Qian, Z. et al. (2008) Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc. Natl. Acad. Sci. U.S.A., 105, 15535-15540.
47. Helmlinger, G., Yuan, F., Dellian, M., Jain, R.K. (1997) Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat. Med., 3, 177-182.
48. Chen, J., Li, T., Liu, Q., Jiao, H., Yang, W., Liu, X., Huo, Z. (2014) Clinical and prognostic significance of HIF-1alpha, PTEN, CD44v6, and survivin for gastric cancer: a meta-analysis. PLoS One, 9, e91842.
49. Kitajima, Y.,Miyazaki, K. (2013) The critical impact of HIF-1a on gastric cancer biology. Cancers, 5, 15-26.
50. Zhang, J., Guo, H., Zhu, J.S., Yang, Y.C., Chen, W.X., Chen, N.W. (2014) Inhibition of phosphoinositide 3-kinase/Akt pathway decreases hypoxia inducible factor-1alpha expression and increases therapeutic efficacy of paclitaxel in human hypoxic gastric cancer cells. Oncol. Lett. 7, 1401-1408.
51. Luo, Y., Lan, L., Jiang, Y.G., Zhao, J.H., Li, M.C., Wei, N.B., Lin, Y.H. (2013) Epithelial-mesenchymal transition and migration of prostate cancer stem cells is driven by cancer-associated fibroblasts in an HIF-1alpha/beta-catenin- dependent pathway. Mol Cells, 36, 138-144.